2025
Characteristics and Outcomes of Patients with Cardiogenic Shock and Clinically Significant Valvular Heart Disease: From the Critical Care Cardiology Trials Network
Carnicelli A, Miller P, Berg D, Aliyev N, Alviar C, Bohula E, Chaudhry S, Chonde M, Chow C, Cooper H, Daniels L, Fordyce C, Ghafghazi S, Goldfarb M, Gorder K, Hamilton M, Keane R, Kontos M, Kusner J, Leibner E, Loriaux D, Menon V, Nair R, Newby L, Oduah M, Palazzolo M, Patolia H, Pierce J, Pierce M, Potter B, Proudfoot A, Roswel R, Schnell G, Shaw J, Sidhu K, Sinha S, Varshney A, Katz J, Diepen S, Morrow D. Characteristics and Outcomes of Patients with Cardiogenic Shock and Clinically Significant Valvular Heart Disease: From the Critical Care Cardiology Trials Network. Journal Of Cardiac Failure 2025 PMID: 39970998, DOI: 10.1016/j.cardfail.2025.01.019.Peer-Reviewed Original ResearchValvular heart diseaseCardiac intensive care unitCritical Care Cardiology Trials NetworkCardiogenic shockIn-hospital mortalityClinically significant valvular heart diseaseSignificant valvular heart diseaseSevere valvular heart diseaseHeart diseaseHigher in-hospital mortality ratesAssociated with higher in-hospital mortality ratesIn-hospital mortality rateTrials NetworkOutcomes of patientsTertiary cardiac intensive care unitUnadjusted in-hospital mortalityIntensive care unitMitral regurgitationValve interventionAortic stenosisCICU admissionCS admissionsOdds ratioCare unitConsecutive admissions
2024
PATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study
Becker R, Harnett B, Wayne D, Mardis R, Meganathan K, Steen D. PATCH (Preferred Attachment Strategy for Optimal Electrocardiograms)-1 Study. Clinical Research In Cardiology 2024, 114: 497-506. PMID: 39527276, DOI: 10.1007/s00392-024-02572-6.Peer-Reviewed Original ResearchStable cardiovascular diseaseAmbulatory clinic visitsAmbulatory clinic settingCardiovascular diseaseS-ECGClinical research coordinatorsClinical indicationsClinic visitsResearch coordinatorsValvular heart diseaseCoronary artery diseaseMedical practiceParticipantsEssential hypertensionClinical settingLead placementAtrial fibrillationHeart diseaseHeart failureTreatment decisionsArtery diseaseST-TElectrocardiographyBaselineHeart rhythmCardiac Disease in Pregnancy
Cifuentes J, Fardelmann K. Cardiac Disease in Pregnancy. 2024, 41-53. DOI: 10.1007/978-3-031-62756-9_6.Peer-Reviewed Original ResearchCongenital heart diseaseCardiac diseaseHeart diseasePregnant patientsPrevalence of congenital heart diseaseMaternal-fetal medicine physiciansRegistry of pregnanciesHigh-risk pregnanciesPregnancy-related mortalityProportion of patientsIncreasing maternal ageValvular heart diseasePeripartum planFetal outcomesMaternal morbidityPostpartum managementAntepartum periodDelivery hospitalizationsChronic medical conditionsComplication rateMaternal ageProspective studyDiabetes mellitusCardiothoracic surgeonsPregnancyArtificial Intelligence for Cardiovascular Care—Part 1: Advances JACC Review Topic of the Week
Elias P, Jain S, Poterucha T, Randazzo M, Lopez Jimenez F, Khera R, Perez M, Ouyang D, Pirruccello J, Salerno M, Einstein A, Avram R, Tison G, Nadkarni G, Natarajan V, Pierson E, Beecy A, Kumaraiah D, Haggerty C, Avari Silva J, Maddox T. Artificial Intelligence for Cardiovascular Care—Part 1: Advances JACC Review Topic of the Week. Journal Of The American College Of Cardiology 2024, 83: 2472-2486. PMID: 38593946, DOI: 10.1016/j.jacc.2024.03.400.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsEnhanced image qualityHuman expertsLeverage AIEvaluation benchmarkArtificial intelligenceAI modelsAI advancementsDetect diseaseTraining methodsImage qualityReduced ejection fractionEvolving technologyValvular heart diseaseReal-world efficacyEjection fractionProvider experienceHeart diseaseTechnologyCardiovascular carePatient careUnique characteristicsIntelligenceBenchmarksGuidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography
Zoghbi W, Jone P, Chamsi-Pasha M, Chen T, Collins K, Desai M, Grayburn P, Groves D, Hahn R, Little S, Kruse E, Sanborn D, Shah S, Sugeng L, Swaminathan M, Thaden J, Thavendiranathan P, Tsang W, Weir-McCall J, Gill E. Guidelines for the Evaluation of Prosthetic Valve Function With Cardiovascular Imaging: A Report From the American Society of Echocardiography Developed in Collaboration With the Society for Cardiovascular Magnetic Resonance and the Society of Cardiovascular Computed Tomography. Journal Of The American Society Of Echocardiography 2024, 37: 2-63. PMID: 38182282, DOI: 10.1016/j.echo.2023.10.004.Peer-Reviewed Original ResearchConceptsProsthetic valve functionEvaluation of prosthetic valve functionCardiac magnetic resonanceValve repairComputed tomographyValve functionTransesophageal echocardiographyValve replacementAmerican Society of Echocardiography guidelinesThree-dimensional transesophageal echocardiographyAmerican Society of EchocardiographySociety of Cardiovascular Computed TomographyCardiac computed tomographyPercutaneous valve repairCardiovascular magnetic resonanceCardiovascular computed tomographyValvular heart diseaseCardiac valvular diseaseFirst-line methodAmerican SocietyEchocardiography guidelinesTricuspid regurgitationTransthoracic approachEchocardiographic techniquesValvular disease
2023
Clinical Profile and Outcomes of Rheumatic Heart Disease Patients Undergoing Surgical Valve Procedures in Uganda
Rwebembera J, Chang A, Kitooleko S, Kaudha G, de Loizaga S, Nalule M, Ahabwe K, Zhang W, Okello E, Sinha P, Mwambu T, Sable C, Beaton A, Longenecker C. Clinical Profile and Outcomes of Rheumatic Heart Disease Patients Undergoing Surgical Valve Procedures in Uganda. Global Heart 2023, 18: 62. PMID: 38028964, PMCID: PMC10655755, DOI: 10.5334/gh.1260.Peer-Reviewed Original ResearchConceptsRheumatic heart diseaseAcute rheumatic feverComplication of acute rheumatic feverHeart diseaseValve surgery proceduresPost-operative survivalCohort of patientsProportion of patientsOutcome of operated patientsRetrospective cohort studyFifteen-year survivalValvular heart diseaseChronic valvular heart diseaseLong-term complicationsMortality of patientsValve surgeryValve repairValvular operationsValve proceduresPublic health problemRe-operationValve replacementSurgical managementUgandan patientsValvular interventionsCharacteristics and outcomes of elderly patients undergoing protected percutaneous coronary intervention with impella mechanical circulatory support
Jakob P, Falah B, Abu-Much A, Lansky A, Basir M, Schonning M, Zhou Z, Batchelor W, Grines C, O'neill W, Stahli B. Characteristics and outcomes of elderly patients undergoing protected percutaneous coronary intervention with impella mechanical circulatory support. European Heart Journal 2023, 44: ehad655.2209. DOI: 10.1093/eurheartj/ehad655.2209.Peer-Reviewed Original ResearchHigh-risk percutaneous coronary interventionPercutaneous coronary interventionMechanical circulatory supportYears of ageCirculatory supportMyocardial infarctionCoronary interventionElderly patientsClinical outcomesStroke/transient ischemic attackMain percutaneous coronary interventionMultivariable Cox regression modelsSevere valvular heart diseaseLeft ventricular ejection fractionLower body mass indexBaseline SYNTAX scoreTransient ischemic attackHigh-risk patientsGlomerular filtration ratePrior myocardial infarctionVentricular ejection fractionValvular heart diseaseBody mass indexCox regression modelRisk of mortalityAbstract 14916: Clinical and Socioeconomic Factors Associated With Time to Surgery and Preoperative Mortality in Surgery-Eligible Patients With Rheumatic Valvular Heart Disease in Uganda
Doh C, An C, Chang A, Rwebembera J, Mwambu T, Beaton A, Nakagaayi D, Vega P, Sable C, Lwabi P, Longenecker C. Abstract 14916: Clinical and Socioeconomic Factors Associated With Time to Surgery and Preoperative Mortality in Surgery-Eligible Patients With Rheumatic Valvular Heart Disease in Uganda. Circulation 2023, 148: a14916-a14916. DOI: 10.1161/circ.148.suppl_1.14916.Peer-Reviewed Original ResearchRheumatic heart diseaseFactors associated with timeLikelihood of surgeryPreoperative mortalitySurgical indicationsAwaiting surgeryAtrial fibrillationIncreased likelihood of surgeryValvular rheumatic heart diseaseHistory of infective endocarditisHistory of atrial fibrillationMultivariate Cox proportional hazards modelAdvanced rheumatic heart diseaseHeart diseaseRate of surgical interventionRheumatic valvular heart diseaseNYHA class I/IISurgery-eligible patientsNYHA class III/IVMedian follow-upAssociated with increased mortalityTime to surgeryCohort of patientsReceipt of surgeryValvular heart diseaseRacial and Ethnic Differences in the Risk of Ischemic Stroke After Nontraumatic Intracerebral Hemorrhage
Simonetto M, Sheth K, Ziai W, Iadecola C, Zhang C, Murthy S. Racial and Ethnic Differences in the Risk of Ischemic Stroke After Nontraumatic Intracerebral Hemorrhage. Stroke 2023, 54: 2401-2408. PMID: 37462054, PMCID: PMC10529487, DOI: 10.1161/strokeaha.123.043160.Peer-Reviewed Original ResearchConceptsNon-Hispanic white patientsNon-Hispanic blacksIschemic strokeIntracerebral hemorrhageHispanic patientsWhite patientsAtrial fibrillationICH patientsHigh riskNon-Hispanic black patientsCox proportional hazards modelIncident ischemic strokeRetrospective cohort studyNontraumatic intracerebral hemorrhageValvular heart diseaseTime of dischargeLarge heterogeneous cohortProportional hazards modelNon-Hispanic whitesICH hospitalizationsCardiovascular comorbiditiesMedian followCohort studyVascular comorbiditiesConcomitant diagnosis
2022
Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the Future
Ahmad Y, Madhavan M, Baron S, Forrest J, Borger M, Leipsic J, Cavalcante J, Wang D, McCarthy P, Szerlip M, Kapadia S, Makkar R, Mack M, Leon M, Cohen D. Clinical Research on Transcatheter Aortic Valve Replacement for Bicuspid Aortic Valve Disease: Principles, Challenges, and an Agenda for the Future. Structural Heart 2022, 7: 100102. PMID: 37275317, PMCID: PMC10236801, DOI: 10.1016/j.shj.2022.100102.Peer-Reviewed Original ResearchTranscatheter aortic valve replacementBicuspid aortic valve diseaseSurgical aortic valve replacementAortic valve replacementAortic valve diseaseValve replacementClinical researchValve diseaseValvular heart diseaseDesign of RCTsProcedural therapiesProspective registryHeart diseaseExclusion criteriaRisk scorePatientsRCTsDiseaseCardiovascular communityMultidisciplinary workshopSelection biasTrialsInternational expertsPotential studiesRegistryBenefits and harms of oral anticoagulants for atrial fibrillation in nursing home residents with advanced dementia
Ouellet GM, O'Leary JR, Leggett CG, Skinner J, Tinetti ME, Cohen AB. Benefits and harms of oral anticoagulants for atrial fibrillation in nursing home residents with advanced dementia. Journal Of The American Geriatrics Society 2022, 71: 561-568. PMID: 36310367, PMCID: PMC9957933, DOI: 10.1111/jgs.18108.Peer-Reviewed Original ResearchConceptsNursing home residentsAtrial fibrillationAdvanced dementiaHome residentsStroke riskLong-stay nursing home residentsMedicare Part D claimsDementia-related mortalityGuideline-recommended thresholdHarms of anticoagulationRetrospective cohort studyMultivariable survival analysisValvular heart diseaseRisk of deathPart D claimsMonths of lifeMinimum Data SetAnticoagulant discontinuationAnticoagulated individualsMean CHAVASc scoreCause mortalityMultivariable adjustmentOral anticoagulantsCohort studyGlobal and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990–2017
Nejad M, Ahmadi N, Mohammadi E, Shabani M, Sherafati A, Aryannejad A, Rezaei N, Ghanbari A, Yoosefi M, Aminorroaya A, Shabani M, Rezaei N, Salavati T, Larijani B, Naderimagham S, Farzadfar F. Global and regional burden and quality of care of non-rheumatic valvular heart diseases: a systematic analysis of Global Burden of Disease 1990–2017. International Journal For Quality In Health Care 2022, 34: mzac026. PMID: 35434737, DOI: 10.1093/intqhc/mzac026.Peer-Reviewed Original ResearchConceptsQuality of care indexGlobal Burden of DiseaseNon-rheumatic valvular heart diseaseQuality of careSociodemographic indexBurden of diseaseQuality of care index scoreLow SDI quintileWHO world regionsSociodemographic index countriesHeart diseaseHealthcare qualityHealthcare accessCare indexEastern Mediterranean RegionHealthcare systemRegional burdenGlobal burdenWestern Pacific RegionValvular heart diseaseHealthcareAge groupsQuintilePrimary measureCareNon-vitamin K antagonist oral anticoagulants in patients with valvular heart disease
Fanaroff A, Vora A, Lopes R. Non-vitamin K antagonist oral anticoagulants in patients with valvular heart disease. European Heart Journal Supplements 2022, 24: a19-a31. PMID: 35185406, PMCID: PMC8850709, DOI: 10.1093/eurheartj/suab151.Peer-Reviewed Original ResearchNon-vitamin K antagonist oral anticoagulantsVitamin K antagonistsValvular heart diseaseRandomized controlled trialsAtrial fibrillationOral anticoagulantsHeart diseaseMitral stenosisControlled trialsBenefits of non-vitamin K antagonist oral anticoagulantsSafety of non-vitamin K antagonist oral anticoagulantsTreated with vitamin K antagonistsManagement of atrial fibrillationMechanical prosthetic mitral valveRheumatic mitral stenosisSevere mitral stenosisMechanical valve prosthesesMechanical prosthetic valvesProsthetic mitral valveK antagonistsStroke prophylaxisConsensus guidelinesMitral valveTranscatheter valvesProsthetic valves
2021
Cardiac Computed Tomography in Cardio-Oncology JACC: CardioOncology Primer
Lopez-Mattei JC, Yang EH, Ferencik M, Baldassarre LA, Dent S, Budoff MJ. Cardiac Computed Tomography in Cardio-Oncology JACC: CardioOncology Primer. JACC CardioOncology 2021, 3: 635-649. PMID: 34988472, PMCID: PMC8702811, DOI: 10.1016/j.jaccao.2021.09.010.Peer-Reviewed Original ResearchAtherosclerotic cardiovascular diseaseSubclinical atherosclerotic cardiovascular diseaseCancer patientsPericardial diseaseCardiac CTCancer treatment-related cardiovascular toxicityValvular heart diseaseCardiac computed tomographyCardiac magnetic resonanceCardiac tumorsCardiovascular complicationsCardiovascular riskCalcium scoreHeart failureNoncancer patientsCardiovascular toxicityHeart diseaseCardiovascular diseaseCT scanComputed tomographyPatientsRadiation therapy treatmentTherapy treatmentDiseaseNew subspecialtyCharacteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study
Huang X, Dhruva SS, Yuan X, Bai X, Lu Y, Yan X, Liu J, Li W, Hu D, Ji R, Gao M, Miao F, Li J, Ge J, Krumholz HM, Li J. Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study. BMJ Open 2021, 11: e052946. PMID: 34732492, PMCID: PMC8572400, DOI: 10.1136/bmjopen-2021-052946.Peer-Reviewed Original ResearchConceptsSevere valvular heart diseaseValvular heart diseaseHigh operative riskRheumatic originValve interventionHospital outcomesOperative riskCommon etiologyPrimary diagnosisHeart diseaseSeverity of VHDTypes of VHDCommon valvular heart diseaseMultivariable logistic regression analysisDegenerative valvular heart diseaseOutcomes of patientsCross-sectional studyLogistic regression analysisTwo-stage random sampling designClinical characteristicsFrequent etiologyPredominant etiologyTricuspid regurgitationAdult patientsPatient characteristicsHaemophilus Parainfluenzae mural endocarditis with large atrial septal defect and peripheral embolization
Bae JY, Murugiah K, McLeod GX, Anwer M, Howes CJ. Haemophilus Parainfluenzae mural endocarditis with large atrial septal defect and peripheral embolization. Journal Of Cardiology Cases 2021, 25: 149-152. PMID: 35261698, PMCID: PMC8888727, DOI: 10.1016/j.jccase.2021.08.002.Peer-Reviewed Case Reports and Technical NotesAtrial septal defectLarge atrial septal defectMural endocarditisInfective endocarditisSeptal defectLV massRisk factorsLeft ventriclePrior intravenous drug useBlood culture growthHemorrhagic cerebral eventsIntra-cardiac tumorPost-pericardiotomy syndromeRecent dental workIntravenous drug useUrgent surgical interventionValvular heart diseaseMitral valve repairVentricular septal defectCeftriaxone therapyPeripheral embolizationCerebral eventsDuke criteriaSymptom onsetSplenic infarct2020 ACC/AHA guideline for the management of patients with valvular heart disease A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Members W, Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM, Thompson A, Toly C, Members A, O'Gara PT, Beckman JA, Levine GN, Al-Khatib SM, Armbruster A, Birtcher KK, Ciggaroa J, Deswal A, Dixon DL, Fleisher LA, de las Fuentes L, Goldberger Z, Gorenek B, Haynes N, Hernandez A, Hlatky M, Joglar J, Jones W, Marine J, Mark D, Palaniappan L, Piano M, Spatz E, Tamis-Holland J, Wijeysundera D, Woo Y. 2020 ACC/AHA guideline for the management of patients with valvular heart disease A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal Of Thoracic And Cardiovascular Surgery 2021, 162: e183-e353. PMID: 33972115, DOI: 10.1016/j.jtcvs.2021.04.002.Peer-Reviewed Original ResearchClinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes
Gevaert AB, Tibebu S, Mamas MA, Ravindra NG, Lee SF, Ahmad T, Ko DT, Januzzi JL, Van Spall HGC. Clinical phenogroups are more effective than left ventricular ejection fraction categories in stratifying heart failure outcomes. ESC Heart Failure 2021, 8: 2741-2754. PMID: 33934542, PMCID: PMC8318507, DOI: 10.1002/ehf2.13344.Peer-Reviewed Original ResearchConceptsLeft ventricular ejection fractionChronic obstructive pulmonary diseaseHazard ratioComposite outcomePrimary outcomeAtrial fibrillationHeart diseaseComposite cardiovascular deathEjection fraction categoriesSecondary composite outcomeHeart failure outcomesPrimary composite outcomeObstructive pulmonary diseaseVentricular ejection fractionValvular heart diseaseCoronary heart diseaseGreater prognostic informationDifferent risk categoriesCause deathHF rehospitalizationPredominant comorbiditiesCardiovascular deathHF trialsBaseline characteristicsSecondary outcomes
2020
Cardiovascular severe maternal morbidity in pregnant and postpartum women: development and internal validation of risk prediction models
Malhamé I, Danilack V, Raker C, Hardy E, Spalding H, Bouvier B, Hurlburt H, Vrees R, Savitz D, Mehta N. Cardiovascular severe maternal morbidity in pregnant and postpartum women: development and internal validation of risk prediction models. BJOG An International Journal Of Obstetrics & Gynaecology 2020, 128: 922-932. PMID: 32946639, DOI: 10.1111/1471-0528.16512.Peer-Reviewed Original ResearchConceptsSevere maternal morbidityMaternal morbidityRisk prediction modelDelivery hospitalisationChronic hypertensionGestational hypertensionMaternal ageInternal validationPostpartum modelNon-Hispanic black race/ethnicityBlack race/ethnicityObstetric teaching hospitalAcute heart failureRetrospective cohort studyPoor pregnancy outcomesValvular heart diseaseStrongest predictorRace/ethnicityRisk assessment toolCardiogenic shockSevere hypertensionCohort studyMultiple gestationsPregnancy outcomesHeart failureA Systematic Review of Cardiogenic Shock in the Setting of Severe Aortic Stenosis: Prevalence, Management, and Outcomes
Essa M, Essa M, Berardi C, Aneni E, Fleming J, Trejo-Paredes M, Bellumkonda L, F. Faridi K, Sugeng L. A Systematic Review of Cardiogenic Shock in the Setting of Severe Aortic Stenosis: Prevalence, Management, and Outcomes. American Journal Of Cardiovascular Research 2020, 1-9. DOI: 10.31487/nl.ajcr.2020.01.02.Peer-Reviewed Original ResearchBalloon aortic valvuloplastySevere aortic stenosisSurgical valve replacementCardiogenic shockAortic stenosisSystematic reviewCommon valvular heart diseaseProcedure-related complicationsValvular heart diseaseTranscatheter aortic valveHospital mortalityAortic valvuloplastyValve replacementPrimary outcomeCirculatory supportFatal conditionAortic valveHeart diseaseStudy protocolBetter outcomesPatientsMedical emergencyStenosisAdditional outcomesMortality
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply